Advice
In the absence of a submission from the holder of the marketing authorisation.
melatonin prolonged-release tablets (Circadin) are not recommended for use within NHSScotland as monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice24KB (PDF)
Medicine details
- Medicine name:
- melatonin 2mg prolonged-release tablets (Circadin)
- SMC ID:
- 500/08
- Indication:
- for the short-term treatment of primary insomnia
- Pharmaceutical company
- Lundbeck Ltd
- BNF chapter
- Central nervous system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 11 August 2008